Molecular findings in Barrett's epithelium

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Barrett's metaplasia is a major risk factor for esophageal adenocarcinoma.
• Histologic changes involve genetic and epigenetic alterations in epithelial cells and stroma.
• These alterations disrupt cell cycle regulation, leading to uncontrolled growth and evasion of apoptosis.

Purpose of the Study:

• To review the genetic and epigenetic disturbances associated with Barrett's carcinogenesis.
• To understand the molecular mechanisms underlying the progression from metaplasia to adenocarcinoma.
• To assess the potential of these alterations as diagnostic biomarkers.

Main Methods:

• Literature review of genetic and epigenetic changes in Barrett's metaplasia and adenocarcinoma.
• Analysis of key molecular events including cell cycle dysregulation, apoptosis evasion, and angiogenesis.
• Comparison of genetic alterations with those found in other epithelial malignancies.

Main Results:

• Genetic and epigenetic events promote self-sufficiency and ignore anti-growth signals.
• Instability in cell turnover is driven by apoptosis evasion and unlimited replicative potential.
• Key genetic changes include loss of p16 and p53, increased cyclin expression, and loss of Rb and APC.
• Sustained angiogenesis may precede invasion by genetically unstable cells.

Conclusions:

• The genetic and epigenetic alterations in Barrett's carcinogenesis are similar to other epithelial cancers.
• These alterations disrupt normal cellular processes, facilitating malignant transformation.
• Currently, these molecular changes are not tumor or stage-specific, limiting their diagnostic value as biomarkers.